Background One aim of unilateral postmastectomy breast reconstruction (BR) is to restore symmetry with the contralateral breast. As such, unilateral prosthetic reconstruction often requires a contralateral symmetry procedure (CSP). There is sparse literature on the impact of CSPs on long-term patient-reported outcomes (PROs) such as satisfaction and health-related quality of life (HRQoL). This study aims to describe PROs following CSPs, using a validated PRO tool, BREAST-Q. The hypothesis is that CSPs are associated with greater patient-reported satisfaction and HRQoL. Methods This study is a single institutional analysis of prospectively collected BREAST-Q scores of patients who underwent unilateral prosthetic BR during 2011 to 2015. Women 18 years and older with BREAST-Q scores measured ! 9months after BR with or without CSP(s) at the time of expander replacement were included. Patients were classified into four subcohorts: augmentation, mastopexy, reduction, and no symmetry procedure (controls). Sociodemographic, clinical characteristics, and BREAST-Q scores were analyzed. Multivariable linear regression was performed. Results Of 553 patients, 67 (12%) underwent contralateral augmentation, 68 (12%) mastopexy, 93(17%) reduction, and 325 (59%) were controls. Mean follow-up time was 52 months. Satisfaction with breast and outcomes were higher in the augmentation compared with the control groups (p ¼ 0.01). On multivariable analysis, augmentation remained an independent predictor of satisfaction with breast (p ¼ 0.04). Physical well-being scores were lower for contralateral mastopexy and reduction compared with the controls with a trend toward statistical significance on multivariable models. Psychological and sexual well-being was similar across groups. Conclusion Prosthetic reconstruction with contralateral breast augmentation was associated with greater satisfaction with breast and reconstructive outcome. In contrast, breast reduction and mastopexy procedures demonstrated equivalent satisfaction with breasts compared with controls but may be associated with lower physical well-being. Such information can be used to improve the shared decisionmaking process for women who choose unilateral prosthetic BR.
One of the principal aesthetic aims of unilateral postmastectomy breast reconstruction (BR) is to create a breast mound symmetric with the remaining natural breast. When compared with autologous transfer, it may be more challenging for the plastic surgeon to achieve adequate and reliable symmetry using prosthetic techniques.
1,2 Implants tend to create a more rounded and full appearance to the breast, especially in the upper pole, which often does not resemble the remaining natural breast. For this reason, a contralateral symmetry procedure (CSP) is often performed in this setting. Three CSPs commonly performed include augmentation, mastopexy, and reduction.
1,2 The choice is based on the shape, size, and projection of the remaining natural breast, as well as patient preference. Despite the high number of CSPs completed for unilateral implant BR, most outcomes are derived from subjective physician opinion with sparse data on patient-reported outcomes (PROs). [3] [4] [5] [6] [7] The absence of PROs limits plastic surgeons' ability to counsel patients effectively about postoperative health-related quality of life (HRQoL) and to properly align expectations. The BREAST-Q is a validated BR-specific instrument used to evaluate patient-reported satisfaction and HRQoL. 8 The satisfaction with breast domain of the BREAST-Q reconstruction module was chosen as the primary outcome because it specifically asks questions about and measures postreconstruction symmetry. The study aim is to compare PROs following unilateral implant-based BR with and without one of the three common symmetry procedures. The hypothesis is that patient-reported satisfaction improves when prosthesisbased BR is combined with a symmetry procedure.
Methods
This study is a single institutional retrospective analysis of prospectively collected BREAST-Q scores from patients who underwent unilateral implant-based BR during 2011 to 2015. Before initiation, the study was approved by the Institutional Review Board. Inclusion criteria consisted of women who underwent staged immediate unilateral prosthetic reconstruction with placement of a tissue expander at the time of mastectomy. Patients subsequently underwent a tissue expander exchange to permanent silicone or saline implant with or without a simultaneous CSP such as augmentation, mastopexy, and reduction. The details of the symmetry procedure were at the discretion of the operating surgeon but included both subglandular and submuscular implant placements as well as both vertical and wise pattern mammoplasty and mastopexy. CSP procedures were defined using Current Procedural Terminology codes. A minimum follow-up time of 9 months following the exchange and symmetry procedure was required for inclusion. Exclusion criteria included patients with a prior history of breast cancer treated with radiotherapy or previous elective breast surgery (e.g., augmentation, mastopexy, reduction). To ensure a homogenous cohort, we excluded patients who underwent nipple-sparing mastectomy, tissue expander removal/replacement for infection, any autologous BR such as latissimus or deep inferior epigastric artery flap, delayed symmetry procedure, combined symmetry procedures such as mastopexy augmentation, and revisionary or secondary breast reconstructive surgeries following the exchange operation (e.g., fat grafting). Based on the status and type of CSP performed, patients were divided into four subcohorts: augmentation, mastopexy, reduction, and no symmetry (control).
The most recent available BREAST-Q reconstruction module scores including satisfaction with breasts, satisfaction with outcomes, psychosocial well-being, sexual well-being, and physical well-being were included in the analysis. The BREAST-Q scores of each domain were obtained by transforming the scale item responses with the Q-score software program. 8 The transformed scores range from 0 to 100, and higher scores indicate greater satisfaction and HRQoL. Demographic (e.g., age, body mass index [BMI] ) and oncological variables (e.g., chemotherapy, postmastectomy radiotherapy) were noted for each patient. Follow-up time was calculated as the time duration between implant exchange with or without symmetry procedure and the most recent available BREAST-Q score. Pairwise comparison was done separately for each of the symmetry procedures with the no symmetry group as control. Continuous variables were compared using t-test or analysis of variance, whereas categorical variables were analyzed using the chi-square or Fisher's exact test statistics. Multivariable linear regression analyses were performed to account for baseline confounders. All analyses were done using STATA 12.0 (College Station, TX) and a p< 0.05 was considered as significant.
Results
A total of 553 patients met selection criteria for inclusion in the study. Of these, 228 (41%) patients underwent a CSP--67 (12.1%)underwent contralateral augmentation, 68 (12.3%) mastopexy, and 93 (16.8%) reduction. The 325 (58.8%) patients who did not undergo a symmetry procedure were categorized into the no symmetry or control group.
Patient demographics and clinical characteristics are listed in ►Table 1. There was no significant difference in the age distribution of patients among all groups (p ¼ 0.62). Mean BMI in the augmentation, mastopexy, reduction, and no symmetry group was 23, 26, 29, and 25, respectively. These values were significantly different (p < 0.01). The proportion of patients who received postmastectomy radiotherapy (PMRT) also differed between the augmentation, mastopexy, reduction, and no symmetry groups, that is, 10, 15, 33, and 20%, respectively (p < 0.01). The proportion of patients receiving chemotherapy and mean follow-up time did not differ significantly between the groups. Overall follow-up time to the BREAST-Q assessment was distributed evenly across all subcohorts (p ¼ 0.61), and the mean follow-up time was 52 months for the entire cohort.
Augmentation versus No Symmetry: Univariable Analysis
The scores for satisfaction with breast and satisfaction with outcomes were significantly higher, on average by 6 and 7 points, respectively, in the augmentation group than in the control group (p ¼ 0.01 for both; ►Table 2). There was no significant difference in the psychosocial, sexual, and physical well-being scores between the two groups.
Mastopexy or Reduction versus No Symmetry: Univariable Analysis
Mean physical well-being scores were significantly lower, on average by 5 points, in both the mastopexy and reductions groups compared with controls (p < 0.05; ►Tables 3 and 4). There was no significant difference in the scores for satisfaction with breast, satisfaction with outcomes or psychosocial, and sexual well-being between the CSP groups and controls (p > 0.05).
Post Hoc Analyses after Excluding Women with PMRT
To eliminate the effect of postmastectomy radiotherapy on the statistical analyses, separate posthoc univariate analysis after excluding women with PMRT was performed. These data are similar to those of the original cohort, that is, women with contralateral augmentation reported greater satisfaction with breast (p ¼ 0.03) and outcomes (p ¼ 0.02) compared with the control group (►Supplementary Table S1 , available in online version only). Physical well-being was significantly lower in women who underwent contralateral mastopexy or breast reduction (p 0.05).
Multivariable Analyses
Multivariable linear regression analysis was performed to adjust for potential confounders. Augmentation was associated with increased satisfaction with breasts, by 5 points (p ¼ 0.04; ►Table 5). Elevated BMI, chemotherapy, and PMRT were also independent predictors of lowered patient satisfaction with breasts (p < 0.05; ►Table 5).
After adjustment, scores for physical well-being remained lower and trended toward statistical significance for both the mastopexy (p ¼ 0.07; ►Supplementary Table S2 , available in online version only) and breast reduction groups (p ¼ 0.09, ►Supplementary Table S3 , available in online version only). PMRT was also identified as an independent predictor of reduced physical well-being scores (p < 0.01; ►Supplementary Tables S2 and S3, available in online version only).
Discussion
To our knowledge, this study is the first comparing long-term PROs, using a validated and BR-specific instrument, in the setting of unilateral prosthetic reconstruction with and without a symmetry procedure. The study results demonstrate that women who choose a contralateral augmentation are significantly more likely to be satisfied with their breasts and overall outcome when compared with those who did not undergo a balancing procedure. The satisfaction with breast domain of the BREAST-Q asks questions about breast size, symmetry, and appearance in clothing. A greater than 5-point difference in this study was measured for the satisfaction with breast and outcome domains when comparing the augmentations to the controls, a change significant enough to be interpreted as a clinically minimal important difference.
8,9
Several factors may contribute to the enhanced postoperative satisfaction of women undergoing contralateral breast augmentation. The adage of "replacing like with like" is highly applicable in this instance, similar to other aspects of plastic surgery. The best way to match an implant is with another implant. Even a small implant augmentation will create a more projecting breast with upper pole fullness akin to the reconstructed breast. Another important observation in this study is the low BMI of patients undergoing augmentation, which was the lowest of all study groups. These patients would seemingly be ideal candidates for implant reconstruction in general since they have less tissue at the lateral chest wall aesthetic unit, which in large body types creates a challenge to blend smoothly into the permanent implant reconstruction.
10
In contrast to the outcomes with contralateral augmentation, there was no difference in reported satisfaction with breasts or outcomes between patients who underwent either a mastopexy or breast reduction compared with controls. These findings suggest limitations of current mastopexy and reduction techniques in achieving reliable symmetry with implant reconstructions. Moreover, these findings may encompass secondary longitudinal changes that occur with lifted and reduced breasts, such as recurrent ptosis. While short-term follow-up may not highlight such differences, the lengthy mean follow-up time of 4 years captures the temporal changes that commonly occur with skin-tightening procedures. In contrast to the elective bilateral mastopexy or reduction procedures, aging effects are particularly magnified when the comparator breast is a static and stable implant reconstruction. Consideration also needs to be given to the impact of weight fluctuations that can accompany postmastectomy hormonal ablation therapy and its effect on symmetry.
There are two other studies identified in the literature that measure the outcomes associated with CSP following unilateral prosthetic reconstruction. A Taiwanese study, reported subjective outcomes of good to excellent, in women who underwent a contralateral augmentation.
11 Another study used the BREAST-Q as a categorical, not continuous variable, to assess postoperative outcomes in 582 women who underwent unilateral implant-based reconstruction. The authors reported improved outcomes, defined as a raw BREAST-Q score ! 4, in women with contralateral augmentation, compared with contralateral mastopexy or reduction.
12
The physical well-being domain of the BREAST-Q reconstruction module asks questions about sensory disturbances, such as pain, aches, tightness, pulling, and nagging involving the chest and surrounding areas. It is noteworthy that the physical well-being scores were significantly lower in the reduction and mastopexy than in the no symmetry group. On multivariable regression analysis, the reduction in physical well-being domain score trended toward significance (►Supplementary Tables S2 and S3, available in online version only). Barone et al also reported that women with contralateral augmentation achieved significantly better physical well-being than their comparator groups, mastopexy or reduction.
12 Nonetheless, as they did not include a control group without a symmetry procedure, the findings of greater chest wall morbidity following reduction or mastopexy are unique to this study. As these procedures involve additional incisions, tissue manipulation, and scars on the contralateral side, women should be advised about potential trade-offs when considering either reduction or mastopexy. Not surprisingly, PMRT also significantly lowered physical well-being scores as well.
The main strength of this study is its use of a conditionspecific PRO instrument, BREAST-Q reconstruction module, to evaluate long-term outcomes of CSPs in a homogenous cohort from a single high-volume center. The lengthy followup period has also added objective evidence about some of the longitudinal shortcomings of prosthetic relative to autologous BR. That is, over time, patient-reported satisfaction with implants can be less stable than with autologous transfer. The study also has some limitations. Preoperative satisfaction with breasts was not available. Patients' baseline 
Conclusion
Prosthetic reconstruction with contralateral breast augmentation was associated with significantly greater satisfaction with breasts and reconstructive outcome compared with the controls. In contrast, patients undergoing mastopexy or breast reduction demonstrated no improvement in satisfaction and simultaneously experienced lower physical wellbeing. Such information can be used to improve the shared decision-making process for women who choose unilateral prosthetic BR.
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